Ocular features in mucopolysaccharidosis: diagnosis and treatment

Ocular features in mucopolysaccharidosis: diagnosis and treatment is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1109912834
P356DOI10.1186/S13052-018-0559-9
P2888exact matchhttps://scigraph.springernature.com/pub.10.1186/s13052-018-0559-9
P932PMC publication ID6238255
P698PubMed publication ID30442167

P2093author name stringElena Piozzi
Alessandra Del Longo
Fiammetta Schweizer
P2860cites workOcular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidosesQ26785517
Rarebit perimetry and optic disk topography in pediatric glaucoma.Q33293993
Acquired Brown's syndrome associated with Hurler-Scheie's syndromeQ33647120
Glaucoma in a case of Hurler diseaseQ33652177
Deep anterior lamellar keratoplasty for Maroteaux-Lamy syndromeQ33697007
Corneal hysteresis in mucopolysaccharidosis I and VI.Q33792543
The natural history of MPS I: global perspectives from the MPS I RegistryQ34304968
Glaucoma as an early complication of Hurler's diseaseQ35605021
Mucopolysaccharidoses and the eye.Q36369188
Indications and outcomes of deep anterior lamellar keratoplasty in childrenQ37776048
Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis.Q37790219
Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosisQ37963981
Ocular manifestations as key features for diagnosing mucopolysaccharidosesQ37972588
An update on ocular involvement in mucopolysaccharidoses.Q38123035
Use of new imaging in detecting and monitoring ocular manifestations of the mucopolysaccharidoses.Q38856624
Outcomes of keratoplasty in the mucopolysaccharidoses: an international perspectiveQ38968704
Acute Glaucoma in Systemic Mucopolysaccharidosis I-SQ39740152
Dry-eye syndrome after allogeneic stem-cell transplantation in childrenQ46841459
Bull's eye maculopathy and subfoveal deposition in two mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.Q50228699
Objective Quantification of Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis.Q50906563
Measuring corneal clouding in patients suffering from mucopolysaccharidosis with the Pentacam densitometry programme.Q53108962
Glaucoma in the Maroteaux-Lamy syndrome.Q54104355
Central Corneal Thickness in Mucopolysaccharidosis II and VIQ58871754
Optic nerve head swelling and optic atrophy in the systemic mucopolysaccharidosesQ68369003
Glaucoma in mucopolysaccharidosis 1-H/SQ71888000
Altered corneal stromal matrix organization is associated with mucopolysaccharidosis I, III and VIQ77753269
The ocular features of the mucopolysaccharidosesQ81767672
Ocular axial length and corneal refraction in children with mucopolysaccharidosis (MPS I-Hurler)Q84419613
Ocular and electrophysiological findings in a patient with Sly syndromeQ88368127
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P433issueSuppl 2
P407language of work or nameEnglishQ1860
P921main subjectmucopolysaccharidosisQ1479681
eye diseaseQ3041498
diagnosisQ16644043
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)125
P577publication date2018-11-16
P1433published inItalian Journal of PaediatricsQ15762169
P1476titleOcular features in mucopolysaccharidosis: diagnosis and treatment
P478volume44

Reverse relations

cites work (P2860)
Q90578333A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management
Q92049089Assessing the impact of the five senses on quality of life in mucopolysaccharidoses
Q59340075Clinical hints to diagnosis of attenuated forms of Mucopolysaccharidoses
Q99238544Distribution and Function of Glycosaminoglycans and Proteoglycans in the Development, Homeostasis and Pathology of the Ocular Surface
Q90193327Ophthalmological Findings in Mucopolysaccharidoses
Q90484456Retinal Degeneration in MPS-IIIA Mouse Model
Q59340100The new frame for Mucopolysaccharidoses

Search more.